Search

Your search keyword '"Herbrich, Shelley M."' showing total 29 results

Search Constraints

Start Over You searched for: Author "Herbrich, Shelley M." Remove constraint Author: "Herbrich, Shelley M."
29 results on '"Herbrich, Shelley M."'

Search Results

2. Figure S3. Differential expression of MDM2 and PARP1 in B-ALL patient samples. from Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia

3. Data from Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia

4. Figure S2. CyTOF-SPADE analysis shows upregulation of p53 and Bax proteins by treatment with PLK1 inhibitor volasertib (BI6727) in primary B-ALL. from Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia

5. Figure S1. Notch-induced cell death in B-ALL. from Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia

6. Supplementary Materials and Methods, Figures 1 - 14, Table 1 from Molecular Biomarkers of Residual Disease after Surgical Debulking of High-Grade Serous Ovarian Cancer

7. Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via altered Runx1 splicing

9. BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis

10. A phase 1b/2 study of azacitidine with PD‐L1 antibody avelumab in relapsed/refractory acute myeloid leukemia

11. Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferative disease in mice via altered Runx1 splicing

13. Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia

14. Abstract 342: S63845, a novel BH3 mimetic Mcl-1 inhibitor synergizes with midostaurin to induce potent apoptosis in acute myeloid leukemia cells carrying FLT3-ITD mutations

18. Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer

19. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin

20. Abstract 2273: Targeting the PI3K/AKT/mTOR pathway for the treatment of metaplastic breast cancer: Does location of PIK3CA mutation or histology affect response

21. A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer

23. Abstract 2273: Mechanistic and functional implications of FABP4 in ovarian cancer metastasis

24. Clinical next generation sequencing to identify actionable aberrations in a phase I program

25. Refining statistics clarifies leukaemic stem cell genomics.

26. Molecular Biomarkers of Residual Disease after Surgical Debulking of High-Grade Serous Ovarian Cancer

27. Clinical next-generation sequencing to identify actionable alterations in a phase I program.

28. Statistical Inference from Multiple iTRAQ Experiments without Using Common Reference Standards

29. A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer

Catalog

Books, media, physical & digital resources